We are live on ! Find out more
SSA

Schonfeld Strategic Advisors Portfolio holdings

AUM $14.2B
1-Year Est. Return 37.17%
This Fund
S&P 500
This Quarter Est. Return
+8.18%
1 Year Est. Return
+37.17%
3 Year Est. Return
+107.75%
5 Year Est. Return
+136.39%
10 Year Est. Return
+833.52%
AUM
$2.25B
AUM Growth
+$405M
Cap. Flow
+$2.31B
Cap. Flow %
102.69%
Top 10 Hldgs %
14.53%
Holding
1,145
New
406
Increased
187
Reduced
178
Closed
367

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$93.2M
2
FTV icon
Fortive
FTV
+$32.4M
3
KDP icon
Keurig Dr Pepper
KDP
+$30.9M
4
WYNN icon
Wynn Resorts
WYNN
+$24.7M
5
GB
Global Blue Group Holding
GB
+$21.3M

Top Sells

Rank Stock Value
1
EQH icon
Equitable Holdings
EQH
+$22.7M
2
FPAC.U
Far Point Acquisition Corporation Units, each consisting of one share of Class A common stock, $0.00
FPAC.U
+$22.4M
3
SHW icon
Sherwin-Williams
SHW
+$21.1M
4
MS icon
Morgan Stanley
MS
+$12.4M
5
V icon
Visa
V
+$11.9M

Sector Composition

Rank Sector Weight
1 Healthcare 22.31%
2 Consumer Discretionary 16.07%
3 Industrials 13.87%
4 Technology 11.32%
5 Financials 7.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPY icon
1
State Street SPDR S&P 500 ETF Trust
SPY
$778B
$96.7M 4.3%
332,791
+327,391
+6,063% +$93.2M
TNDM icon
2
Tandem Diabetes Care
TNDM
$1.17B
$35.5M 1.58%
829,264
-207,336
-20% -$7.24M
FTV icon
3
Fortive
FTV
$19B
$33.6M 1.49%
+632,433
New +$32.4M
STZ icon
4
Constellation Brands
STZ
$22.2B
$30.4M 1.35%
140,987
+94,462
+203% +$20.1M
KDP icon
5
Keurig Dr Pepper
KDP
$40.4B
$24.3M 1.08%
1,046,803
+976,403
+1,387% +$30.9M
TTWO icon
6
Take-Two Interactive
TTWO
$43B
$22.5M 1%
163,400
+91,327
+127% +$11.7M
WYNN icon
7
Wynn Resorts
WYNN
$10.1B
$21.4M 0.95%
168,661
+166,609
+8,119% +$24.7M
GB
8
DELISTED
Global Blue Group Holding
GB
$21.2M 0.94%
+2,199,999
New +$21.3M
RCL icon
9
Royal Caribbean
RCL
$78.7B
$20.9M 0.93%
160,879
+146,393
+1,011% +$17.2M
CCC.U
10
DELISTED
Churchill Capital Corp
CCC.U
$20.3M 0.9%
+2,000,000
New +$20.2M
MRK icon
11
Merck
MRK
$324B
$20.2M 0.9%
298,427
+14,347
+5% +$914K
LOW icon
12
Lowe's Companies
LOW
$116B
$18.5M 0.82%
160,900
+80,651
+101% +$8.4M
STAA icon
13
STAAR Surgical
STAA
$1.16B
$16.4M 0.73%
342,700
+239,100
+231% +$9.79M
BRSL
14
Brightstar Lottery PLC
BRSL
$1.91B
$16.3M 0.73%
827,000
+281,853
+52% +$6.14M
IFF icon
15
International Flavors & Fragrances
IFF
$19.4B
$16.3M 0.72%
117,190
+112,090
+2,198% +$14.7M
TPGH.U
16
DELISTED
TPG Pace Holdings Corp. Units, each consisting of one Class A ordinary share, $.0001 par value, and
TPGH.U
$15.9M 0.71%
1,500,000
– –
CSX icon
17
CSX Corp
CSX
$98.6B
$15.8M 0.7%
641,829
+214,338
+50% +$5.11M
CHDN icon
18
Churchill Downs
CHDN
$6.03B
$15.5M 0.69%
335,880
+275,280
+454% +$13M
TJX icon
19
TJX Companies
TJX
$170B
$14.7M 0.65%
+262,400
New +$13.5M
ECYT
20
DELISTED
Endocyte, Inc. Common Stock
ECYT
$14.6M 0.65%
822,100
+681,900
+486% +$11.7M
NSC icon
21
Norfolk Southern
NSC
$78.8B
$14M 0.62%
77,700
-1,342
-2% -$229K
GWPH
22
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$13.9M 0.62%
80,700
-900
-1% -$130K
DE icon
23
Deere & Co
DE
$170B
$13.8M 0.61%
91,500
+32,561
+55% +$4.68M
BSX icon
24
Boston Scientific
BSX
$65.8B
$13.5M 0.6%
350,200
-30,682
-8% -$1.07M
LLL
25
DELISTED
L3 Technologies, Inc.
LLL
$12.9M 0.57%
60,700
+11,207
+23% +$2.33M
1
2 3 4 5

Similar funds

FGP
Freestone Grove Partners San Francisco, California $14.2B AUM 24.58% 1-Year Est. Return
BBVA
Banco Bilbao Vizcaya Argentaria Madrid, Spain $14.3B AUM 26.23% 1-Year Est. Return
IFP
Independent Franchise Partners London, United Kingdom $14.3B AUM 3.49% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return
X
Xponance Philadelphia, Pennsylvania $14.1B AUM 30.11% 1-Year Est. Return
CM
Capula Management Grand Cayman, Cayman Islands $14.1B AUM 19.14% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $14.5B AUM 5.7% 1-Year Est. Return

Schonfeld Strategic Advisors's Q3 2018 Portfolio in Review

As of Q3 2018, Schonfeld Strategic Advisors held 1,145 positions worth $2.25B, up 22% from $1.84B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Schonfeld Strategic Advisors deployed $2.31B of net new capital in Q3 2018, opening 406 new positions and adding to 187 existing holdings. Its largest new stake was Fortive: 632,433 shares worth $33.6M.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 22% a quarter earlier, followed by Consumer Discretionary and Industrials.

On the sell side, the largest reduction was Equitable Holdings, an estimated $22.7M trimmed.

  • Schonfeld Strategic Advisors's largest Q3 2018 buy was Fortive: 632,433 shares worth $33.6M.
  • Schonfeld Strategic Advisors added most to State Street SPDR S&P 500 ETF Trust in Q3 2018, an estimated $93.2M increase.
  • Schonfeld Strategic Advisors's biggest Q3 2018 reduction was Equitable Holdings, cutting an estimated $22.7M.
  • Schonfeld Strategic Advisors fully exited Far Point Acquisition Corporation Units, each consisting of one share of Class A common stock, $0.00 in Q3 2018, selling an estimated $22.4M.
  • Schonfeld Strategic Advisors's ten largest holdings make up 15% of its $2.25B portfolio in Q3 2018.
  • Schonfeld Strategic Advisors opened 406 new positions and closed 367 in Q3 2018.
  • Schonfeld Strategic Advisors's portfolio value rose 22% quarter-over-quarter to $2.25B.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2018, filed 14 Nov 2018.